Invention Grant
US08815241B2 Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
有权
使用抗血管生成物质和c-kit激酶抑制剂的组合
- Patent Title: Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
- Patent Title (中): 使用抗血管生成物质和c-kit激酶抑制剂的组合
-
Application No.: US13205328Application Date: 2011-08-08
-
Publication No.: US08815241B2Publication Date: 2014-08-26
- Inventor: Yuji Yamamoto
- Applicant: Yuji Yamamoto
- Applicant Address: JP Tokyo
- Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Fish & Richardson P.C.
- Priority: JP2005-322946 20051107
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/506 ; A61K31/47 ; A61P35/00 ; A61K31/4709 ; A61K31/404 ; A61K31/517 ; A61K45/06 ; A61K31/519 ; A61K31/502 ; A61K31/5377 ; A61K31/4439 ; A61K31/4409 ; C07D215/48
Abstract:
The object of the present invention is to find a pharmaceutical composition and a method for treating cancer that show an excellent antitumor effect. Combinational use of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and analogues thereof can result in an excellent antitumor effect when combined with a substance having a c-kit kinase-inhibiting activity.
Public/Granted literature
- US20110293615A1 Use of Combination of Anti-Angiogenic Substance and c-kit Kinase Inhibitor Public/Granted day:2011-12-01
Information query
